Raymond James Financial Services Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.36M | Buy |
|
|||||
|
2024
Q2 | $4.3M | Sell |
|
|||||
|
2024
Q1 | $4.62M | Buy |
|
|||||
|
2023
Q4 | $3.7M | Buy |
|
|||||
|
2023
Q3 | $2.85M | Sell |
|
|||||
|
2023
Q2 | $11.3M | Buy |
|
|||||
|
2023
Q1 | $9.47M | Sell |
|
|||||
|
2022
Q4 | $9.09M | Buy |
|
|||||
|
2022
Q3 | $9.38M | Buy |
|
|||||
|
2022
Q2 | $8.86M | Sell |
|
|||||
|
2022
Q1 | $11M | Sell |
|
|||||
|
2021
Q4 | $12.4M | Sell |
|
|||||
|
2021
Q3 | $12.7M | Sell |
|
|||||
|
2021
Q2 | $12.2M | Sell |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $10.7M | Sell |
|
|||||
|
2020
Q3 | $8.8M | Sell |
|
|||||
|
2020
Q2 | $12.1M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $8.81M | Sell |
|
|||||
|
2019
Q3 | $7.9M | Buy |
|
|||||
|
2019
Q2 | $7.01M | Sell |
|
|||||
|
2019
Q1 | $5.99M | Buy |
|
|||||
|
2018
Q4 | $6.55M | Buy |
|
|||||
|
2018
Q3 | $6.54M | Buy |
|
|||||
|
2018
Q2 | $5.81M | Buy |
|
|||||
|
2018
Q1 | $5.27M | Buy |
|
|||||
|
2017
Q4 | $4.17M | Buy |
|
|||||
|
2017
Q3 | $3.77M | Buy |
|
|||||
|
2017
Q2 | $3.67M | Buy |
|
|||||
|
2017
Q1 | $3.29M | Buy |
|
|||||
|
2016
Q4 | $1.49M | Buy |
|
|||||
|
2016
Q3 | $1.52M | Sell |
|
|||||
|
2016
Q2 | $1.53M | Sell |
|
|||||
|
2016
Q1 | $1.4M | Sell |
|
|||||
|
2015
Q4 | $1.3M | Sell |
|
|||||
|
2015
Q3 | $1.31M | Buy |
|